ABSTRACT Administration of a single dose of estradiol to immature rats gives rise to the appearance of substantial amounts of peroxidase (donor:hydrogen-peroxide oxidoreductase, EC 1.11.1.7) enzyme activity in the uterus. This enzyme induction, which is inhibited by administration of actinomycin D and cycloheximide, can be detected at 4 hr after administration of estradiol, reaches a maximum level by 20 hr, and thereafter declines."The amount of uterine peroxidase seen at 20 hr after a single dose increases with dose from 0.1 to 100 ;g of estradiol. Estrone and estriol also show dose-dependent induction of peroxidase, and the quantitative peroxidase responses to these steroids follow their uterotropic capacities. The antiestrogen CI28, capable of low levels of enzyme induction by itself, can inhibit the induction due to estrogen.
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Solubilization of the uterine enzyme with divalent cations, especially calcium, results in a substantially increased yield of peroxidase. This extraction method provides an enzyme of about 50,000 molecular weight-in distinction to the large aggregated form obtained by the usual extraction with sodium chloride. The significant progress of the last 15 years toward a better understanding of the role of steroid hormones in controlling target cell functions has been possible to a large extent by the elucidation of the steroid-receptor interaction pathway (1-3), coupled with investigations of biochemical parameters whose expression is regulated by these steroids (3) (4) (5) . Studies on the mechanism of estrogen action have used two main model systems. The atrophic rodent uterus, demonstrating dramatic growth response to estrogen, has been widely studied regarding the estrogen-receptor interaction pathway as correlated with tissue growth and control of RNA synthesis (4, 6, 7) . The chick oviduct, after primary steroid stimulation to produce a differentiated, functional organ, responds to estrogen by producing large quantities of the specific protein, ovalbumin (3, 5) . There has been considerable increase in our knowledge of the nature of the hormone regulation of specific protein synthesis resulting from studies with the oviduct model in recent years (8) (9) (10) . However, in the uterine model no analogous specific gene product, characteristically a marker for estrogen action, has been available to allow comparable, detailed studies in this more complex, mammalian steroid target organ. There have been numerous reports of uterine proteins, in particular enzymes, whose concentration are increased after estrogen administration. However, even with those showing significant increases in proportion in the uterus after estrogen stimulation, the extent of the steroid induction is only 5-to 10-fold (11) . Considerable interest has been shown in IP or "induced-protein," an acidic uterine protein first described by Notides and Gorski (12) . Recent studies have shown that this protein, inducible in vitro (13) , is an early'response, detectible by 15 min, and declining in amount after 2 hr (14) . While such a time course of induction The costs of publication of this article were defrayed in part by the payment of page charges from funds made available to support the research which is the subject of the article. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C.
§1734 solely to indicate this fact.
might be consistent with a role of "induced protein" as an early key intermediate protein (15) in estrogen action, it would obviously put expression of this protein prior to the observed increases in macromolecular synthesis involved in the actual growth response of the uterus. Increases in uterine peroxidase (donor:hydrogen-peroxide oxidoreductase, EC 1.11.1.7) content after estrogen administration were reported over 20 years ago by Stotz and coworkers (16) but attributed to an influx of eosinophils into the tissue (17) . More recent evidence, both biochemical (18, 19) and histochemical (20) (21) (22) quickly dissected free of fat and connective tissue, nicked, blotted on hard filter paper to excise luminal fluid, and weighed. Each uterus was minced with a scissors into a 12-ml polycarbonate tube and homogenized, 10 sec with ice cooling in 10 mM Tris-HCI, pH 7.2, buffer (25 mg of tissue per ml unless otherwise stated), with a polytron PT lOST homogenizer at setting 6. After removal of aliquots for DNA analysis (25) , the homogenates were centrifuged for 45 min at 39,000 X g at 20. The hypotonic supernatant fraction contains no peroxidase activity. The peroxidase activity was solubilized by rehomogenizng the 39,000 X g sediment with 10 mM Tris.HCI, pH 7.2, buffer containing 0.6 or 1.2 M NaCl, or more effectively with 0.5 M CaC12. The extract was collected by centrifugation for 45 min at 39,000 X g at 20.
Peroxidase Assay. Assays were performed by modification of the method of Himmelhoch et al. (26) ; the rate of oxidation of guaiacol was measured at 25°. The assay mixture, 3.0 ml total volume, contained 13 mM guaiacol and 0.3 mM H202 in the extraction buffer. The reaction was started by the addition of enzyme (extract), and initial rates of guaiacol oxidation were determined from the increase in absorbance at 470 nm for the first minute. An enzyme unit was defined as the amount of enzyme required to produce an increase of 1 absorbance unit/ min under the assay conditions. RESULTS Extraction of Uterine Peroxidase. Since rat uterine peroxidase activity is associated with the endoplasmic reticulum (21) and vesicles (19) and is not found in particulate-free cytosols of hypotonic homogenates, some extraction or solubilization method is necessary. The usual method, based on the work of Klebanoff (17) , effected solubilization by extraction with NaCl. The resultant enzyme shows a very large molecular size, as indicated in Fig. 1, being excluded from Sephadex G-200 along with the major part of the proteins of the NaCl extract. Furthermore, since the enzyme is also excluded from Sepharose 4B, the approximate size of several million daltons would suggest an appreciably larger enzyme than has been reported for other mammalian peroxidase enzymes [for example, 150,000 molecular weight for myeloperoxidase (26) and 300,000 for thyroid (Fig. 4) , peroxidase was first detected at 4 hr, continued to increase in amount until about 20 hr, and declined thereafter. A similar time course is seen in both the castrate and immature rat and after 1 ,Ag of estradiol is given, as well as after the 10-lg dose shown in Fig. 4 . The appreciable standard deviation seen near the peak induction times are believed to result from animal variability in the time at which the peak of activity occurs, since hr gives rise to some subsequent enzymatically assayable peroxidase.
The amount of uterine peroxidase present 20 hr after estradiol administration is clearly dose dependent (Fig. 5) . Although the control animals had detectible activity, 0.1 sg of estradiol effected a significant increase in uterine peroxidase activity. Interestingly, continued increases in peroxidase were seen with 1, 10, and 100 ,ug of estradiol. However, it would appear that this wide range dose response may be due to the fact that only a single dose of estradiol was used. Indeed, on extended daily injections, saturation of the response of uterine peroxidase occurs at lower doses.
Peroxidase and Other Estrogens and Antiestrogen. Dosedependent responses of uterine peroxidase are seen after injection of estrone and estriol also (Fig. 6) . Consistent with the comparable effects of estrone and estradiol on uterine growth and their relative affinities for the cytosol estrogen receptor, about 10 times as much estrone is required to obtain a comparable peroxidase induction seen with estradiol. Estriol is somewhat less dose-effective, especially at the higher dose levels. It is noteworthy that appreciable uterine peroxidase is induced by each of these estrogens.
Antiestrogens, like the Parke-Davis compound C1628 used here, frequently act as weak estrogens themselves. As shown in Table 3 , both 50 and 500 Aig of C1628 gave rise to small amounts of uterine peroxidase, each less than that seen after administration of 0.1 jug of estradiol. However, the simultaneous administration of C1628 with either or 1 To an appreciable extent peroxidase activity would appear to be an appropriate marker for estrogen action in the uterus. As presented in this paper, using the guaiacol assay the enzyme is readily quantitated in individual uteri with a sensitivity that allows its detection as early as 4 hr after estrogen administration. (18, 23) . The higher baseline seen with the assay for water-soluble products and the maximum conversion of about 60% of the estradiol tend to minimize the apparent extent of the stimulation of uterine peroxidase. The evidence that actinomycin D and cycloheximide prevent the steroid-induced appearance of peroxidase confirms evidence from previous histochemical (20) and biochemical (18) reports that macromolecular synthesis is required for uterine expression of the marker. More detailed studies will be needed to establish the timing of required RNA and protein synthesis. All the available evidence concerning uterine peroxidase levels under various hormonal conditions is consistent with the proposed marker function. In addition to the reported absence in the uterus of the immature or ovariectomized host and its induction with estradiol, the variation with the estrus cycle (18, 20, 22) in rats as well as in human beings (28) has been documented. In this report we have shown that the relationship of efficacies of estradiol, estrone, and estriol for induction of uterine peroxidase relates to their previously documented uterotropic activities (29) and with each a dose dependency is observed. Furthermore the quantitative peroxidase results using the antiestrogen, CI628, indicate, as previously suggested, that, while weakly estrogenic itself (30) , C1628 is inhibitory to estrogen action when given with estradiol (31, 32) . Another antiestrogen, nafoxidine or U 11100A, has been recently reported by McNabb and Jmlinck (33) to show a similar effect on uterine (22) .
More detailed studies regarding the macromolecular nature of the hormonal regulation of the uterine peroxidase gene would be enhanced by isolation of purified uterine peroxidase and its mRNA. As suggested by the magnitude of the peroxidase induction, the estrogen-stimulated rat uterus is an appropriate source for purification of this enzyme marker.
